MedTrace Logo

Little Cigar and Cigarillo Warnings for Youth

NCT06413797 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 928

Last updated 2025-12-24

Study results available
· View outcomes & findings →

Summary

This study explores the effect of the little cigars and cigarillos (LCC) warnings on youth who currently use, have ever used, or are susceptible to using LCCs. This study will inform the Food and Drug Administration (FDA) implementation of LCC warnings, which can reduce LCC use and lessen tobacco health disparities among youth.

Conditions

  • Little Cigars and Cigarillos (LCC) Use

Interventions

BEHAVIORAL

FDA warnings + Image

For six days (days 2-7) participants will be contacted and asked to complete a daily survey. As part of the survey, participants will view FDA-proposed LCC warnings with images at 30% size on a cigarillo package. Participants will be contacted each day to be invited to complete the survey for that day of the study protocol.

BEHAVIORAL

FDA Warnings Text-Only

Participants will receive messages including images in 30% size.

BEHAVIORAL

Surgeon General Text-Only Warnings

Participants will receive messages including Surgeon General Text-only Warnings.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Food and Drug Administration (FDA)

    collaborator FED

  • UNC Lineberger Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Leah Ranney, PhD, MA · UNC Lineberger Comprehensive Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-18
Primary Completion
2024-11-25
Completion
2024-11-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06413797 on ClinicalTrials.gov